The drug acts in the collecting tubules:

Questions 262

ATI RN

ATI RN Test Bank

Safety Pharmacology Across the Lifespan ATI Quizlet Questions

Question 1 of 5

The drug acts in the collecting tubules:

Correct Answer: C

Rationale: In this question about drug action in the collecting tubules, the correct answer is C) Potassium-sparing diuretics. Potassium-sparing diuretics act in the collecting tubules by inhibiting sodium reabsorption without causing potassium loss. This mechanism helps in promoting diuresis without the risk of hypokalemia, a common side effect of other diuretics. Option A) Loop diuretics work in the loop of Henle by inhibiting sodium and chloride reabsorption, leading to significant diuresis but also potassium loss. Option B) Thiazide diuretics act in the distal convoluted tubule and promote sodium and water excretion, also causing potassium loss. Option D) Carbonic anhydrase inhibitors work in the proximal convoluted tubule and inhibit bicarbonate reabsorption, not directly acting on the collecting tubules. Understanding the mechanisms of action of different diuretics is crucial in pharmacology to choose the most appropriate drug based on the patient's condition and electrolyte balance. This knowledge is essential for nursing and medical students to provide safe and effective patient care, especially when managing conditions like hypertension, heart failure, or edema where diuretics are commonly prescribed.

Question 2 of 5

Mechanisms of bacterial resistance to anti-microbial agents are the following, EXCEPT:

Correct Answer: B

Rationale: In the context of safety pharmacology, understanding mechanisms of bacterial resistance to antimicrobial agents is crucial for effective patient care. In this quiz question, option B, "Enlarged uptake of the drug by a microorganism," is the correct answer because increased uptake of the antimicrobial agent would not contribute to bacterial resistance; in fact, it would make the agent more effective in combating the bacteria. Option A, "Active transport out of a microorganism or/and hydrolysis of an agent via enzymes produced by a microorganism," is a common mechanism of resistance where bacteria actively pump out the drug or produce enzymes that degrade it, reducing its effectiveness. Option C, "Modification of a drug’s target," refers to altering the target site of the drug so that it no longer binds effectively, leading to resistance. Option D, "Reduced uptake by a microorganism," can also contribute to resistance as it limits the amount of drug available to act on the bacteria. Educationally, this question is important as it reinforces the need for healthcare professionals to stay updated on the mechanisms of antimicrobial resistance to make informed decisions in prescribing medications. Understanding these concepts helps in promoting antimicrobial stewardship and combating the global issue of antibiotic resistance.

Question 3 of 5

Tick the drug belonging to antibiotics-tetracyclines:

Correct Answer: A

Rationale: In this question, the correct answer is A) Doxycycline, which belongs to the class of antibiotics known as tetracyclines. Doxycycline is commonly used to treat various bacterial infections due to its broad-spectrum activity against many pathogens. It is important to differentiate tetracyclines from other classes of antibiotics for effective treatment. Option B) Streptomycin is an aminoglycoside antibiotic used to treat tuberculosis and other bacterial infections. It does not belong to the tetracycline class. Option C) Clarithromycin is a macrolide antibiotic used to treat respiratory tract infections and certain bacterial skin infections. It is not a tetracycline. Option D) Amoxicillin is a penicillin antibiotic commonly used to treat various bacterial infections. It is not classified as a tetracycline antibiotic. Understanding the classification of antibiotics is crucial in pharmacology as it guides healthcare professionals in selecting the most appropriate treatment for bacterial infections. By knowing which drugs belong to specific classes, healthcare providers can ensure effective and targeted therapy, minimizing the risk of antibiotic resistance. Students studying safety pharmacology need to grasp these distinctions to make informed decisions in clinical practice.

Question 4 of 5

Pick out the beta-lactamase inhibitor for co-administration with penicillins:

Correct Answer: D

Rationale: In the context of safety pharmacology across the lifespan, understanding the importance of beta-lactamase inhibitors when co-administering with penicillins is crucial for healthcare professionals. In this scenario, the correct answer is D) All of the above, which includes Clavulanic acid, Sulbactam, and Tazobactam. Clavulanic acid, Sulbactam, and Tazobactam are all beta-lactamase inhibitors that are used in combination with penicillins to enhance their efficacy. Beta-lactamase is an enzyme produced by some bacteria that can break down penicillins, rendering them ineffective. By co-administering a beta-lactamase inhibitor with a penicillin, the inhibitor binds to the beta-lactamase enzyme, preventing it from deactivating the penicillin. This leads to increased bacterial susceptibility to the penicillin and therefore a more effective treatment. Option A) Clavulanic acid is widely used in combination with amoxicillin in medications like Augmentin. Option B) Sulbactam is often combined with ampicillin in drugs like Unasyn. Option C) Tazobactam is used in combination with piperacillin in medications like Zosyn. Understanding the mechanism of action of beta-lactamase inhibitors and their role in potentiating the effects of penicillins is essential for healthcare professionals to make informed decisions when prescribing antibiotics. This knowledge not only contributes to effective patient care but also helps in combating antibiotic resistance, a growing concern in healthcare settings.

Question 5 of 5

Vancomycin has the following unwanted effects:

Correct Answer: C

Rationale: Vancomycin is a powerful antibiotic with a potential for adverse effects. The correct answer, option C, includes "Red neck" syndrome and phlebitis as the unwanted effects of Vancomycin. "Red neck" syndrome presents as redness, flushing, and itching of the upper body and face, while phlebitis is inflammation of the vein where Vancomycin is administered. Option A, pseudomembranous colitis, is associated with antibiotic use but is more commonly linked to broad-spectrum antibiotics like clindamycin or fluoroquinolones rather than Vancomycin. Option B, hepatotoxicity, is a rare adverse effect of Vancomycin but not a common or well-documented side effect compared to the other options. Educationally, understanding the specific adverse effects of Vancomycin is crucial for safe medication administration and monitoring in clinical practice. Nurses and healthcare providers must be aware of these potential effects to promptly recognize and manage them to ensure patient safety and optimal outcomes.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions